Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
12.02
+0.12 (1.01%)
Nov 4, 2024, 4:00 PM EST - Market closed
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $821.22 million as of November 4, 2024. Its market cap has decreased by -4.60% in one year.
Market Cap
821.22M
Enterprise Value
428.05M
1-Year Change
-4.60%
Ranking
Category
Stock Price
$12.02
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.50M to $821.22M, an increase of 75.66%. That is a compound annual growth rate of 9.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 813.00M | 63.29% |
| Dec 29, 2023 | 497.90M | -63.20% |
| Dec 30, 2022 | 1.35B | 6.46% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | 1.75B | 281.78% |
| Dec 31, 2019 | 459.30M | 45.58% |
| Dec 31, 2018 | 315.50M | -32.51% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Embecta | 822.25M |
| EyePoint Pharmaceuticals | 821.94M |
| Healthcare Services Group | 817.20M |
| Perspective Therapeutics | 815.20M |
| Sana Biotechnology | 814.23M |
| Avanos Medical | 807.54M |
| AbCellera Biologics | 804.44M |
| InnovAge Holding | 803.49M |